Subtle signs, serious consequences: pediatric moyamoya disease presenting with seizures and behavioural regression
DOI:
https://doi.org/10.18203/2349-3291.ijcp20263324Keywords:
Moyamoya disease, Pediatric stroke, Cerebral arteriopathy, Encephaloduroarteriosynangiosis, Magnetic resonance angiography, Diagnostic delay, Suzuki StagingAbstract
Moyamoya disease (MMD) is a rare, progressive cerebrovascular arteriopathy characterized by chronic stenosis or occlusion of the terminal internal carotid arteries with compensatory development of a fragile basal collateral network. Although classically described with well-recognized presentations such as stroke, transient ischemic attacks, or seizures, its clinical spectrum in young children is remarkably varied, and early manifestations are often subtle, nonspecific, and easily overlooked or misattributed to more common childhood conditions. This diagnostic ambiguity is compounded in resource-limited settings, where ready access to vascular neuroimaging is not always available, and where a low index of suspicion for a rare cerebrovascular disorder can result in children being managed symptomatically for weeks or months before the underlying diagnosis is considered. We report a 2-year-2-month-old female who presented with a three-month history of behavioural change and regression of previously attained expressive language, followed by transient right-sided weakness, recurrent right-sided focal motor seizures, and progressive hemiparesis. Her early symptoms of irritability and language regression were initially unrecognized as neurological in origin, and even her first episode of transient limb weakness resolved without further evaluation, illustrating how easily the earliest, subtlest features of this disease can be missed. It was only with the onset of recurrent seizures and persistent motor deficits that neuroimaging was pursued. Magnetic resonance imaging demonstrated an acute infarct in the left inferior frontal and parietal regions, while magnetic resonance angiography revealed marked bilateral narrowing of the terminal internal carotid, anterior, and middle cerebral arteries with extensive basal collaterals producing the classical "puff-of-smoke" appearance. Non-contrast computed tomography additionally revealed chronic left hemispheric encephalomalacia with gyriform calcification, indicating an earlier, clinically silent ischemic insult that had gone unrecognized. Digital subtraction angiography confirmed bilateral terminal internal carotid artery stenosis, graded predominantly as Suzuki stage III. The child underwent left-sided encephaloduroarteriosynangiosis (EDAS) with good postoperative recovery of hemiparesis. This case emphasizes that Moyamoya disease must be considered even in the presence of subtle, seemingly unrelated symptoms such as behavioural change or language regression, particularly in settings where diagnostic delay due to varied age-specific presentation and limited imaging access can allow silent, cumulative ischemic injury before diagnosis, underscoring the need for heightened clinical vigilance across all pediatric age groups.
References
Suzuki J, Takaku A. Cerebrovascular "moyamoya" disease: disease showing abnormal net-like vessels in the base of the brain. Arch Neurol. 1969;20(3):288-99.
Kuroda S, Houkin K. Moyamoya disease: current concepts and future perspectives. Lancet Neurol. 2008;7(11):1056-66.
Baba T, Houkin K, Kuroda S. Novel epidemiological features of moyamoya disease. J Neurol Neurosurg Psychiatry. 2008;79(8):900-4.
Khan NT, Islam S, Bari A. A case report of Moyamoya disease presenting as recurrent right-sided weakness. Cureus. 2023;15(5):e39209.
Khanal K, Dhungana S, Gyawali B, Khanal R, Bajracharya B, Neupane N, et al. Pediatric Moyamoya disease in Nepal and challenges in a resource-limited setting: a case report. Clin Case Rep. 2025;13(10):e70947.
Gatti JR, Penn R, Ahmad SA, Sun LR. Seizures in pediatric Moyamoya: risk factors and functional outcomes. Pediatr Neurol. 2023;145:36-40.
Grigore I, Butnariu LI, Schreiner TG, Lupu VV, Lupu A, Darie L, et al. Neurological complications in children with Moyamoya disease: case report and literature review. J Clin Med. 2026;15(6):2242.
Habes HMN, Alshareef RB, Amleh A, Doudin AAA, Habes YMN, Abdulrazzak M, et al. Moyamoya disease in a 2-year-old patient from the Middle East: a case report and literature review. Ann Med Surg (Lond). 2024;86(5):3066-71.
Thapa D, Nimmagadda SP, Philip BA, Kawade SM, Rohila A, Mohammed S. Moyamoya disease in an eight-year-old female child: a case report. Clin Case Rep. 2025;13(11):e71384.
Kuroda S, Fujimura M, Takahashi J, Kataoka H, Ogasawara K, Iwama T, et al.; Research Committee on Moyamoya Disease (Spontaneous Occlusion of Circle of Willis) of the Ministry of Health, Labour and Welfare, Japan. Diagnostic criteria for Moyamoya disease—2021 revised version. Neurol Med Chir (Tokyo). 2022;62(7):307-12.
Fujimura M, Tominaga T, Kuroda S, Takahashi JC, Endo H, Ogasawara K, et al. 2021 Japanese guidelines for the management of Moyamoya disease: guidelines from the Research Committee on Moyamoya Disease and the Japan Stroke Society. Neurol Med Chir (Tokyo). 2022;62(4):165-70.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Ansh Sethi, Rakshitha S. Prasad, Mithila Das Mazumder, Murugan V., Vanshita Verma, Prajwal Chandra C. S.

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.